Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Breast (Edinburgh, Scotland)|December 1, 2023
The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC familiesMaartje A C Schreurs, Teresa Ramón Y Cajal, Muriel A Adank, et al.Cellular and Molecular Life Sciences : CMLS|October 22, 2009
Extracellular matrix formation after transplantation of human embryonic stem cell-derived cardiomyocytesL W van Laake, E G van Donselaar, J Monshouwer-Kloots, et al.Breast Cancer Research : BCR|May 10, 2023
Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profileMarcel Smid, Marjanka K Schmidt, Wendy J C Prager-van der Smissen, et al.Journal of Medical Genetics|February 14, 2026
Later age of natural menopause among women with the pathogenic CHEK2 c.1100delC variant: a validation studyMaartje A C Schreurs, Antoinette Hollestelle, Muriel A Adank, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 3, 2024
Cancer risks for other sites in addition to breast in CHEK2 c.1100delC familiesMaartje A C Schreurs, Marjanka K Schmidt, Antoinette Hollestelle, et al.BMJ Open|October 9, 2024
Cohort profile: a nationwide study in Dutch CHEK2 c.1100delC families using the infrastructure of the HEreditary Breast and Ovarian cancer study Netherlands - Hebon-CHEK2Maartje A C Schreurs, Muriel A Adank, Antoinette Hollestelle, et al.Breast (Edinburgh, Scotland)|November 28, 2025
Outcomes for ER-positive CHEK2 c.1100delC breast cancer patients compared with breast cancer patients without the variantMaartje A C Schreurs, Muriel A Adank, Bernadette A M Heemskerk-Gerritsen, et al.Clinical Psychology Review|July 9, 2020
Effects and moderators of coping skills training on symptoms of depression and anxiety in patients with cancer: Aggregate data and individual patient data meta-analysesL M Buffart, M A C Schreurs, H J G Abrahams, et al.Cancer Medicine|July 4, 2023
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survivalAnna Morra, Maartje A C Schreurs, Irene L Andrulis, et al.Research Square|February 24, 2023
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survivalAnna Morra, Maartje A C Schreurs, Irene L Andrulis, et al.Pageof 2